REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/25/2025
Back to search
Official data from USPTO
STEDABLY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
02/25/2025
Trademark type
Word
Nice classes
5
Filing date
12/12/2018
Registration date
02/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2020
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
09
Owner location
PARMA, IT
Examiner
PAQUIN, SAMUEL
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CHIESI FARMACEUTICI S.P.A.
Representatives
Anthony P. Venturino Vorys, Sater, Seymour and Pease LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of paincardiovascular disordersalimentary tract and metabolism problemsrespiratory diseasesendocrinemusculoskeletalcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmologicalotologicalsneurologicalgastrointestinalhormonaldermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparationsimmunomodulators; hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy productsinfusionsliquidstablets and powders for human use in the treatment of genetic disorders; Therapeutic cellular and stem cell compositions for clinical or medical use
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/21/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/21/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/10/2019
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/10/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/06/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2019
PUBO
PUBLISHED FOR OPPOSITION
06/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/09/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/03/2019
ALIE
ASSIGNED TO LIE
04/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/11/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/11/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/11/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/13/2019
GNRT
NON-FINAL ACTION E-MAILED
03/13/2019
CNRT
NON-FINAL ACTION WRITTEN
03/13/2019
DOCK
ASSIGNED TO EXAMINER
03/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2019
NWAP
NEW APPLICATION ENTERED
12/15/2018
Continuous trademark protection
Get notified about every new filing that threatens STEDABLY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.